

Learn about common and serious Fluticasone/Salmeterol (Advair) side effects, who's most at risk, and when to call your doctor or seek emergency care.
Every medication comes with potential side effects, and Fluticasone/Salmeterol is no exception. The good news is that most people tolerate this medication well, and the most common side effects are mild. But some side effects are serious and require immediate medical attention.
This guide covers what to expect when you start Fluticasone/Salmeterol, which side effects are normal, which ones are concerning, and when to call your doctor.
Fluticasone/Salmeterol is a combination inhaler that contains two medications: Fluticasone (an inhaled corticosteroid that reduces airway inflammation) and Salmeterol (a long-acting bronchodilator that keeps airways open for up to 12 hours). It's sold under brand names including Advair Diskus, Advair HFA, AirDuo RespiClick, and Wixela Inhub.
It's used as a maintenance treatment for asthma and COPD (chronic obstructive pulmonary disease). It is not a rescue inhaler — you should not use it to treat sudden breathing problems. To learn more, see our complete guide on what Fluticasone/Salmeterol is and how it works.
The following side effects occur in a significant percentage of people using Fluticasone/Salmeterol. Most are mild and may improve as your body adjusts to the medication:
Most of these side effects are manageable and don't require stopping the medication. However, if any side effect becomes severe or doesn't go away, talk to your doctor.
Some side effects are serious and require prompt medical attention. Contact your doctor right away — or call 911 — if you experience any of the following:
Fluticasone/Salmeterol carries an FDA boxed warning — the most serious type of safety warning. The Salmeterol component (a long-acting beta-agonist, or LABA) has been associated with an increased risk of asthma-related death. This was identified in a large clinical trial called SMART. Because of this risk:
Fluticasone/Salmeterol (Advair Diskus) is approved for children ages 4 and older. In children, the most significant concern is growth suppression. Inhaled corticosteroids can slow growth velocity, particularly in the first year of treatment. Doctors should monitor height regularly and use the lowest effective dose.
Fluticasone/Salmeterol is classified as Pregnancy Category C, meaning animal studies have shown risk but there are no adequate human studies. However, uncontrolled asthma during pregnancy also poses significant risks. Your doctor will weigh the benefits against the risks. The medication is excreted in breast milk, so caution is advised during breastfeeding.
No dose adjustment is needed for older adults, but they may be more susceptible to cardiovascular effects (increased heart rate, arrhythmias) and bone density loss. Regular monitoring is recommended.
COPD patients using inhaled corticosteroids like Fluticasone have a higher risk of developing pneumonia. Clinical studies showed an increased incidence of pneumonia in COPD patients treated with Fluticasone/Salmeterol compared to Salmeterol alone.
Many common side effects can be reduced or prevented with a few simple strategies:
For more on drug interactions that can increase side effect risk, see our interactions guide.
Fluticasone/Salmeterol is an effective and widely used treatment for asthma and COPD. Most people experience only mild side effects, and many of these improve over time. The key is knowing what to watch for, rinsing your mouth after every use, and communicating with your doctor if something feels off.
If you're having trouble finding Fluticasone/Salmeterol at your pharmacy, use Medfinder to check real-time stock at pharmacies near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.